Phosphonic pseudopeptides as human neutrophil elastase inhibitors--a combinatorial approach. 2011

Marcin Sieńczyk, and Dawid Podgórski, and Aleksandra Błażejewska, and Julita Kulbacka, and Jolanta Saczko, and Józef Oleksyszyn
Division of Medicinal Chemistry and Microbiology, Faculty of Chemistry, Wrocław University of Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland. marcin.sienczyk@pwr.wroc.pl

Here we present a simple and rapid method for the construction of phosphonic peptide mimetic inhibitor libraries-products of Ugi and Passerini multicomponent condensations-leading to the selection of new biologically active phosphonic pseudopeptides. As the starting isonitriles, 1-isocyanoalkylphosphonate diaryl ester derivatives were applied. The structure of the synthesized inhibitors was designed to target human neutrophil elastase, a serine protease whose uncontrolled activity may lead to development of several pathophysiological states such as rheumatoid arthritis, cystic fibrosis or tumor growth and invasion. After screening the inhibitory activity of our constructed libraries, the most active compounds were synthesized as single molecules. One of the obtained inhibitors, Cbz-Met-O-Met-Val(P)(OC(6)H(4)-p-Cl)(2), displayed apparent second-order inhibition value at 40,105M(-1)s(-1) as the diastereomers mixture. Inhibition potency and selectivity of action toward other serine proteases as well as the results of initial in vitro experiments regarding inhibitors influence on cancer cell proliferation are presented.

UI MeSH Term Description Entries
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002918 Chymotrypsin A serine endopeptidase secreted by the pancreas as its zymogen, CHYMOTRYPSINOGEN and carried in the pancreatic juice to the duodenum where it is activated by TRYPSIN. It selectively cleaves aromatic amino acids on the carboxyl side. Alpha-Chymotrypsin Choay,Alphacutanée,Avazyme
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D005881 Gingiva Oral tissue surrounding and attached to TEETH. Gums,Interdental Papilla,Papilla, Interdental,Gum
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012697 Serine Endopeptidases Any member of the group of ENDOPEPTIDASES containing at the active site a serine residue involved in catalysis. Serine Endopeptidase,Endopeptidase, Serine,Endopeptidases, Serine
D014357 Trypsin A serine endopeptidase that is formed from TRYPSINOGEN in the pancreas. It is converted into its active form by ENTEROPEPTIDASE in the small intestine. It catalyzes hydrolysis of the carboxyl group of either arginine or lysine. EC 3.4.21.4. Tripcellim,Trypure,beta-Trypsin,beta Trypsin
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015842 Serine Proteinase Inhibitors Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. Serine Endopeptidase Inhibitor,Serine Endopeptidase Inhibitors,Serine Protease Inhibitor,Serine Protease Inhibitors,Serine Proteinase Antagonist,Serine Proteinase Antagonists,Serine Proteinase Inhibitor,Serine Proteinase Inhibitors, Endogenous,Serine Proteinase Inhibitors, Exogenous,Serine Protease Inhibitors, Endogenous,Serine Protease Inhibitors, Exogenous,Antagonist, Serine Proteinase,Endopeptidase Inhibitor, Serine,Inhibitor, Serine Endopeptidase,Inhibitor, Serine Protease,Inhibitor, Serine Proteinase,Protease Inhibitor, Serine,Proteinase Antagonist, Serine,Proteinase Inhibitor, Serine

Related Publications

Marcin Sieńczyk, and Dawid Podgórski, and Aleksandra Błażejewska, and Julita Kulbacka, and Jolanta Saczko, and Józef Oleksyszyn
March 2011, Bioorganic & medicinal chemistry letters,
Marcin Sieńczyk, and Dawid Podgórski, and Aleksandra Błażejewska, and Julita Kulbacka, and Jolanta Saczko, and Józef Oleksyszyn
March 2024, Molecules (Basel, Switzerland),
Marcin Sieńczyk, and Dawid Podgórski, and Aleksandra Błażejewska, and Julita Kulbacka, and Jolanta Saczko, and Józef Oleksyszyn
July 2012, Journal of medicinal chemistry,
Marcin Sieńczyk, and Dawid Podgórski, and Aleksandra Błażejewska, and Julita Kulbacka, and Jolanta Saczko, and Józef Oleksyszyn
August 2016, Journal of enzyme inhibition and medicinal chemistry,
Marcin Sieńczyk, and Dawid Podgórski, and Aleksandra Błażejewska, and Julita Kulbacka, and Jolanta Saczko, and Józef Oleksyszyn
December 2021, Journal of enzyme inhibition and medicinal chemistry,
Marcin Sieńczyk, and Dawid Podgórski, and Aleksandra Błażejewska, and Julita Kulbacka, and Jolanta Saczko, and Józef Oleksyszyn
July 2018, ACS omega,
Marcin Sieńczyk, and Dawid Podgórski, and Aleksandra Błażejewska, and Julita Kulbacka, and Jolanta Saczko, and Józef Oleksyszyn
September 2002, Bioorganic & medicinal chemistry,
Marcin Sieńczyk, and Dawid Podgórski, and Aleksandra Błażejewska, and Julita Kulbacka, and Jolanta Saczko, and Józef Oleksyszyn
May 2007, Planta medica,
Marcin Sieńczyk, and Dawid Podgórski, and Aleksandra Błażejewska, and Julita Kulbacka, and Jolanta Saczko, and Józef Oleksyszyn
January 2015, Natural product communications,
Marcin Sieńczyk, and Dawid Podgórski, and Aleksandra Błażejewska, and Julita Kulbacka, and Jolanta Saczko, and Józef Oleksyszyn
March 2011, Expert opinion on therapeutic patents,
Copied contents to your clipboard!